AAAAAA

   
Results: 1-16 |
Results: 16
ISSUES IN TESTOSTERONE REPLACEMENT IN OLDER MEN
Authors: BHASIN S BAGATELL CJ BREMNER WJ PLYMATE SR TENOVER JL KORENMAN SG NIESCHLAG E
Citation: S. Bhasin et al., ISSUES IN TESTOSTERONE REPLACEMENT IN OLDER MEN, The Journal of clinical endocrinology and metabolism, 83(10), 1998, pp. 3435-3448
SUPPRESSION OF SPERMATOGENESIS IN MAN-INDUCED BY NAL-GLU GONADOTROPIN-RELEASING-HORMONE ANTAGONIST AND TESTOSTERONE ENANTHATE (TE) IS MAINTAINED BY TE ALONE
Authors: SWERDLOFF RS BAGATELL CJ WANG C ANAWALT BD BERMAN N STEINER B BREMNER WJ
Citation: Rs. Swerdloff et al., SUPPRESSION OF SPERMATOGENESIS IN MAN-INDUCED BY NAL-GLU GONADOTROPIN-RELEASING-HORMONE ANTAGONIST AND TESTOSTERONE ENANTHATE (TE) IS MAINTAINED BY TE ALONE, The Journal of clinical endocrinology and metabolism, 83(10), 1998, pp. 3527-3533
ANDROGENS AND BEHAVIOR IN MEN AND WOMEN
Authors: BAGATELL CJ BREMNER WJ
Citation: Cj. Bagatell et Wj. Bremner, ANDROGENS AND BEHAVIOR IN MEN AND WOMEN, The Endocrinologist, 7(2), 1997, pp. 97-102
DRUG-THERAPY - ANDROGENS IN MEN - USES AND ABUSES (VOL 334, PG 707, 1996)
Authors: BAGATELL CJ
Citation: Cj. Bagatell, DRUG-THERAPY - ANDROGENS IN MEN - USES AND ABUSES (VOL 334, PG 707, 1996), The New England journal of medicine, 334(21), 1996, pp. 1415-1415
DRUG-THERAPY - ANDROGENS IN MEN - USES AND ABUSES
Authors: BAGATELL CJ BREMNER WJ
Citation: Cj. Bagatell et Wj. Bremner, DRUG-THERAPY - ANDROGENS IN MEN - USES AND ABUSES, The New England journal of medicine, 334(11), 1996, pp. 707-714
TESTOSTERONE-INDUCED SUPPRESSION OF LIPOPROTEIN(A) IN NORMAL MEN - RELATION TO BASAL LIPOPROTEIN(A) LEVEL
Authors: MARCOVINA SM LIPPI G BAGATELL CJ BREMNER WJ
Citation: Sm. Marcovina et al., TESTOSTERONE-INDUCED SUPPRESSION OF LIPOPROTEIN(A) IN NORMAL MEN - RELATION TO BASAL LIPOPROTEIN(A) LEVEL, Atherosclerosis, 122(1), 1996, pp. 89-95
ANDROGEN AND PROGESTAGEN EFFECTS ON PLASMA-LIPIDS
Authors: BAGATELL CJ BREMNER WJ
Citation: Cj. Bagatell et Wj. Bremner, ANDROGEN AND PROGESTAGEN EFFECTS ON PLASMA-LIPIDS, Progress in cardiovascular diseases, 38(3), 1995, pp. 255-271
DOSE EFFECTS OF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST, NAL-GLU, COMBINED WITH TESTOSTERONE ENANTHATE ON GONADOTROPIN-LEVELS IN NORMAL MEN
Authors: BAGATELL CJ RIVIER JE BREMNER WJ
Citation: Cj. Bagatell et al., DOSE EFFECTS OF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST, NAL-GLU, COMBINED WITH TESTOSTERONE ENANTHATE ON GONADOTROPIN-LEVELS IN NORMAL MEN, Fertility and sterility, 64(1), 1995, pp. 139-145
THE DIRECT PITUITARY EFFECT OF TESTOSTERONE TO INHIBIT GONADOTROPIN-SECRETION IN MEN IS PARTIALLY MEDIATED BY AROMATIZATION TO ESTRADIOL
Authors: BAGATELL CJ DAHL KD BREMNER WJ
Citation: Cj. Bagatell et al., THE DIRECT PITUITARY EFFECT OF TESTOSTERONE TO INHIBIT GONADOTROPIN-SECRETION IN MEN IS PARTIALLY MEDIATED BY AROMATIZATION TO ESTRADIOL, Journal of andrology, 15(1), 1994, pp. 15-21
METABOLIC AND BEHAVIORAL-EFFECTS OF HIGH-DOSE, EXOGENOUS TESTOSTERONEIN HEALTHY-MEN
Authors: BAGATELL CJ HEIMAN JR MATSUMOTO AM RIVIER JE BREMNER WJ
Citation: Cj. Bagatell et al., METABOLIC AND BEHAVIORAL-EFFECTS OF HIGH-DOSE, EXOGENOUS TESTOSTERONEIN HEALTHY-MEN, The Journal of clinical endocrinology and metabolism, 79(2), 1994, pp. 561-567
PHYSIOLOGICAL LEVELS OF ESTRADIOL STIMULATE PLASMA HIGH-DENSITY LIPOPROTEIN(2) CHOLESTEROL LEVELS IN NORMAL MEN
Authors: BAGATELL CJ KNOPP RH RIVIER JE BREMNER WJ
Citation: Cj. Bagatell et al., PHYSIOLOGICAL LEVELS OF ESTRADIOL STIMULATE PLASMA HIGH-DENSITY LIPOPROTEIN(2) CHOLESTEROL LEVELS IN NORMAL MEN, The Journal of clinical endocrinology and metabolism, 78(4), 1994, pp. 855-861
EFFECTS OF ENDOGENOUS TESTOSTERONE AND ESTRADIOL ON SEXUAL-BEHAVIOR IN NORMAL YOUNG MEN
Authors: BAGATELL CJ HEIMAN JR RIVIER JE BREMNER WJ
Citation: Cj. Bagatell et al., EFFECTS OF ENDOGENOUS TESTOSTERONE AND ESTRADIOL ON SEXUAL-BEHAVIOR IN NORMAL YOUNG MEN, The Journal of clinical endocrinology and metabolism, 78(3), 1994, pp. 711-716
POTENCY DIFFERENCES IN GNRH ANTAGONISTS - REPLY
Authors: BAGATELL CJ BREMNER WJ
Citation: Cj. Bagatell et Wj. Bremner, POTENCY DIFFERENCES IN GNRH ANTAGONISTS - REPLY, Fertility and sterility, 62(1), 1994, pp. 205-206
PRESERVATION OF FERTILITY DESPITE SUBNORMAL GONADOTROPIN AND TESTOSTERONE LEVELS AFTER CESSATION OF PULSATILE GONADOTROPIN-RELEASING-HORMONE THERAPY IN A MAN WITH KALLMANNS-SYNDROME
Authors: BAGATELL CJ PAULSEN CA BREMNER WJ
Citation: Cj. Bagatell et al., PRESERVATION OF FERTILITY DESPITE SUBNORMAL GONADOTROPIN AND TESTOSTERONE LEVELS AFTER CESSATION OF PULSATILE GONADOTROPIN-RELEASING-HORMONE THERAPY IN A MAN WITH KALLMANNS-SYNDROME, Fertility and sterility, 61(2), 1994, pp. 392-394
COMPARISON OF A GONADOTROPIN-RELEASING-HORMONE ANTAGONIST PLUS TESTOSTERONE (T) VERSUS-T ALONE AS POTENTIAL MALE CONTRACEPTIVE REGIMENS
Authors: BAGATELL CJ MATSUMOTO AM CHRISTENSEN RB RIVIER JE BREMNER WJ
Citation: Cj. Bagatell et al., COMPARISON OF A GONADOTROPIN-RELEASING-HORMONE ANTAGONIST PLUS TESTOSTERONE (T) VERSUS-T ALONE AS POTENTIAL MALE CONTRACEPTIVE REGIMENS, The Journal of clinical endocrinology and metabolism, 77(2), 1993, pp. 427-432
SINGLE-DOSE ADMINISTRATION OF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST, NAL-LYS (ANTIDE) TO HEALTHY-MEN
Authors: BAGATELL CJ CONN PM BREMNER WJ
Citation: Cj. Bagatell et al., SINGLE-DOSE ADMINISTRATION OF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST, NAL-LYS (ANTIDE) TO HEALTHY-MEN, Fertility and sterility, 60(4), 1993, pp. 680-685
Risultati: 1-16 |